查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1662299

2025 年全球自行注射市场报告

Self-Injections Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年自行注射市场规模将强劲成长。到 2029 年，这一数字将成长至 141.3 亿美元，复合年增长率为 8.2%。预测期内的成长可归因于疫情和远端医疗的影响、新兴市场的扩张、以患者为中心的医疗保健、药物输送优势以及个人化医疗趋势。预测期内的主要趋势包括智慧技术的整合、生技药品的使用增加、小型化和穿戴式装置、增强的安全功能以及自动注射器的采用。

糖尿病患者数量的增加预计将推动未来自行注射市场的成长。糖尿病是一种由胰臟（产生胰岛素的器官）产生的胰岛素不足引起的疾病，它会导致血糖分解并引起严重的健康问题，例如心臟病、视力丧失和肾臟疾病。自行注射可以让糖尿病患者自行注射胰岛素和其他药物，有助于调节血糖值并防止过量摄取糖，而无需医疗专业人员的协助。例如，根据总部位于比利时的全球糖尿病盛行率、治疗和护理综合资料资讯来源IDF糖尿病地图集，全球糖尿病患者数量预计将增加1.4亿，从2030年的6.43亿增加到2045年的7.83亿。目前，全球有5.37亿成年人患有糖尿病，其中75%以上居住在中低收入国家。因此，糖尿病患者数量的增加对自行注射市场的扩张贡献巨大。

远端保健和远端医疗的兴起预计将在未来几年推动自行注射市场的成长。远端保健是利用通讯技术远端提供广泛的医疗服务和讯息，而远端医疗则专注于远距临床咨询和医疗服务。这些数位健康平台支援虚拟咨询，并允许医疗保健提供者远端开立自行注射药物。患者还可以从虚拟训练课程中受益，以了解如何正确地进行自行注射。此外，远端保健还可以即时监控患者的服药依从性、持续的疾病管理，以及轻鬆取得远距药局服务进行药物管理。远端保健的便利性，尤其是在疫情期间，提高了患者的参与度，改善了整体获得专科护理的机会，大大促进了自行注射市场的成长。例如，根据美国政府资讯提供者Telehealth.HHS.gov的数据，2023年第四季远距远端保健使用者数量达到约21,883,731人，较上一季增加2,783,159人（13%）。因此，远端保健和远端医疗的兴起正在推动自行注射市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球自行注射市场的 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球自行注射市场：成长率分析
  • 全球自行注射市场表现：规模与成长，2019 年至 2024 年
  • 全球自行注射市场预测：规模与成长，2024-2029 年，2034 年
  • 全球自行注射总目标市场 (TAM)

第六章 市场细分

  • 全球自行注射市场类型、效能及预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 配方
  • 全球自行注射市场（依给药途径划分）：2019-2024 年、2024-2029 年、2034 年绩效及预测
  • 皮肤
  • 循环系统或肌肉骨骼系统
  • 循环系统
  • 中枢神经系统
  • 全球自行注射市场（按剂量、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 单一剂量
  • 多剂量
  • 全球自行注射市场（按应用、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 自体免疫疾病
  • 荷尔蒙失调
  • 肿瘤学
  • 罕见疾病
  • 疼痛管理
  • 呼吸治疗
  • 其他的
  • 全球自行注射市场依通路划分：2019-2024 年、2024-2029 年、2034 年业绩及预测
  • 医院药房
  • 诊所
  • 药局
  • 网路药局
  • 全球自行注射市场：按类型、性能和预测对设备进行细分，2019-2024 年、2024-2029 年、2034 年
  • 预填充式注射器
  • 自动注射器
  • 微针装置
  • 穿戴式註射器
  • 全球自行注射市场：按类型、性能和预测细分的配方，2019-2024 年、2024-2029 年、2034 年
  • 生技药品
  • 疫苗
  • 小分子
  • 组合产品

第七章 区域和国家分析

  • 全球自行注射市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球自行注射市场（依国家/地区划分）、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 自行注射市场：竞争格局
  • 自行注射市场：公司简介
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Bristol-Myers Squibb Company
  • Credence MedSystems Inc.
  • Dali Medical Devices Ltd.
  • Eli Lilly and Company
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • Merck & Co. Inc.
  • Owen Mumford Limited
  • Pfizer Inc.
  • PharmaJet Inc.
  • Recipharm AB
  • Schott AG
  • SHL Group Limited
  • Terumo Corporation

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年自行注射市场：提供新机会的国家
  • 2029 年自行注射市场：细分市场将带来新机会
  • 2029 年自行注射市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r22934

Self-injection refers to the act of administering medications or drugs through a device by an individual to themselves without the assistance of a medical professional. This practice allows patients to independently manage their medication regimen.

The primary types of self-injections encompass devices and formulations. These devices enable patients to self-administer medications that require injection without relying on medical professionals. Self-injection devices are utilized for various routes of administration such as skin, circulatory or musculoskeletal systems, organs, and the central nervous system. Dosage types include single-dose and multi-dose, catering to applications in autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. These devices are distributed through various channels including hospitals, pharmacies, clinics, chemists, and online pharmacies.

The self injections market research report is one of a series of new reports from The Business Research Company that provides self injections market statistics, including self injections industry global market size, regional shares, competitors with a self injections market share, detailed self injections market segments, market trends and opportunities, and any further data you may need to thrive in the self injections industry. This self injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-injections market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising chronic diseases, improved patient empowerment, regulatory support, preference for home healthcare, cost-effectiveness.

The self-injections market size is expected to see strong growth in the next few years. It will grow to $14.13 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic impact and remote treatment, expansion into emerging markets, patient-centric healthcare, advantages in drug delivery, personalized medicine trends. Major trends in the forecast period include smart technology integration, rise in biologics usage, miniaturization and wearable devices, enhanced safety features, adoption of autoinjectors.

The increasing number of diabetic patients is anticipated to drive the growth of the self-injections market in the future. Diabetes is a condition where the pancreas, an organ responsible for producing insulin, generates an insufficient amount of insulin, leading to the breakdown of blood sugar and resulting in severe health conditions such as heart disease, vision loss, and kidney disease. Self-injections allow diabetic patients to administer insulin and other medications themselves, helping to regulate blood sugar levels and prevent excess sugar without the need for assistance from a medical professional. For example, according to the IDF Diabetes Atlas, a Belgium-based global resource offering comprehensive data on diabetes prevalence, treatment, and care, the global number of diabetes cases is expected to rise from 643 million in 2030 to 783 million by 2045, an increase of 140 million cases. Currently, 537 million adults live with diabetes, with more than 75% residing in low- and middle-income countries. Therefore, the growing number of diabetic patients is significantly contributing to the expansion of the self-injections market.

The rise of telehealth and telemedicine is expected to drive the growth of the self-injections market in the future. Telehealth involves the use of telecommunications technology to deliver a wide range of healthcare services and information remotely, while telemedicine focuses specifically on remote clinical consultations and healthcare delivery. These digital health platforms enable virtual consultations, allowing healthcare providers to prescribe self-injectable medications from a distance. Patients also benefit from virtual training sessions that ensure they administer self-injections correctly. Additionally, telehealth facilitates real-time monitoring of patient adherence, ongoing disease management, and easy access to telepharmacy services for medication delivery. The convenience of telehealth, especially during pandemics, enhances patient engagement and improves overall access to specialized care, significantly contributing to the growth of the self-injections market. For example, according to Telehealth.HHS.gov, a U.S. government information provider, telehealth usage reached approximately 21,883,731 users in Q4 2023, marking an increase of 2,783,159 users, or 13%, compared to the previous quarter. Thus, the increase in telehealth and telemedicine is driving the expansion of the self-injections market.

Innovation in insulin injection solutions is a key trend in the self-injections market, with major companies focusing on developing new products to gain a competitive edge. For example, in September 2022, Terumo Corporation, a Japan-based medical device company, launched FineGlide, a sterile pen needle designed for patients requiring regular insulin injections or other self-medication. FineGlide prioritizes patient comfort by featuring a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness during injections. The inclusion of Thin Wall Technology improves flow rate and reduces injection force, enhancing the overall experience for patients and promoting drug compliance. This focus on product innovation demonstrates the commitment of major companies to meet the evolving needs of patients in the self-injections market.

Major players in the self-injections market are focusing on the development of smart injecting devices to gain a competitive advantage. In March 2022, Pfizer Inc., a prominent US-based pharmaceutical company, introduced ENBREL SmartClic in Australia. This innovative self-injecting device is designed for patients undergoing treatment with ENBREL, a tumor necrosis factor (TNF) inhibitor prescribed for conditions like Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and Psoriatic Arthritis (PsA). ENBREL SmartClic features an automated, reusable design with user-friendly elements, including a one-button initiation, a larger grip compared to the Enbrel Auto-Injector, and injection speed control. The device is accompanied by a smartphone app, providing additional features such as reminders, injection history recording, site tracking, and streamlined reports. Patients can access these features on their smartphones and share the information with healthcare professionals, enhancing the overall self-injection experience for those dealing with chronic inflammatory diseases.

In June 2022, Dr. Reddy Labs, an India-based pharmaceutical manufacturer, made a significant acquisition by purchasing an injectable portfolio from Eton Pharma for $50 million. This strategic move by Dr. Reddy's aimed to accelerate and expand the availability of affordable medications for patients. The acquisition included new portfolios such as injections and recipes, allowing Dr. Reddy's to diversify its product offerings and strengthen its position in the pharmaceutical market. Eton Pharma, a US-based pharmaceutical manufacturer, contributed to Dr. Reddy's efforts to broaden its pharmaceutical portfolio, signaling a strategic expansion into injectable medications.

Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

North America was the largest region in the self injections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self injections market consists of sales of auto-injectors, needle-free injectors, pen injectors and wearable injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Self-Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The self-injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Devices; Formulations
  • 2) By Route Of Administration: Skin; Circulatory Or Musculoskeletal; Organs; Central Nervous System
  • 3) By Dosage: Single Dose; Multi Dose
  • 4) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
  • 5) By Distribution Channel: Hospitals Pharmacies; Clinics; Chemist; Online Pharmacies
  • Subsegments:
  • 1) By Devices: Pre-Filled Syringes; Auto-Injectors; Microneedle Devices; Wearable Injectors
  • 2) By Formulations: Biologics; Vaccines; Small Molecules; Combination Products
  • Companies Mentioned: AbbVie Inc.; Antares Pharma Inc.; Baxter International Inc.; Bayer AG; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Self-Injections Market Characteristics

3. Self-Injections Market Trends And Strategies

4. Self-Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Self-Injections Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Self-Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Self-Injections Market Growth Rate Analysis
  • 5.4. Global Self-Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Self-Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Self-Injections Total Addressable Market (TAM)

6. Self-Injections Market Segmentation

  • 6.1. Global Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Devices
  • Formulations
  • 6.2. Global Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin
  • Circulatory Or Musculoskeletal
  • Organs
  • Central Nervous System
  • 6.3. Global Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Dose
  • Multi Dose
  • 6.4. Global Self-Injections Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.5. Global Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals Pharmacies
  • Clinics
  • Chemist
  • Online Pharmacies
  • 6.6. Global Self-Injections Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-Filled Syringes
  • Auto-Injectors
  • Microneedle Devices
  • Wearable Injectors
  • 6.7. Global Self-Injections Market, Sub-Segmentation Of Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biologics
  • Vaccines
  • Small Molecules
  • Combination Products

7. Self-Injections Market Regional And Country Analysis

  • 7.1. Global Self-Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Self-Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Self-Injections Market

  • 8.1. Asia-Pacific Self-Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Self-Injections Market

  • 9.1. China Self-Injections Market Overview
  • 9.2. China Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Self-Injections Market

  • 10.1. India Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Self-Injections Market

  • 11.1. Japan Self-Injections Market Overview
  • 11.2. Japan Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Self-Injections Market

  • 12.1. Australia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Self-Injections Market

  • 13.1. Indonesia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Self-Injections Market

  • 14.1. South Korea Self-Injections Market Overview
  • 14.2. South Korea Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Self-Injections Market

  • 15.1. Western Europe Self-Injections Market Overview
  • 15.2. Western Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Self-Injections Market

  • 16.1. UK Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Self-Injections Market

  • 17.1. Germany Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Self-Injections Market

  • 18.1. France Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Self-Injections Market

  • 19.1. Italy Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Self-Injections Market

  • 20.1. Spain Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Self-Injections Market

  • 21.1. Eastern Europe Self-Injections Market Overview
  • 21.2. Eastern Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Self-Injections Market

  • 22.1. Russia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Self-Injections Market

  • 23.1. North America Self-Injections Market Overview
  • 23.2. North America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Self-Injections Market

  • 24.1. USA Self-Injections Market Overview
  • 24.2. USA Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Self-Injections Market

  • 25.1. Canada Self-Injections Market Overview
  • 25.2. Canada Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Self-Injections Market

  • 26.1. South America Self-Injections Market Overview
  • 26.2. South America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Self-Injections Market

  • 27.1. Brazil Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Self-Injections Market

  • 28.1. Middle East Self-Injections Market Overview
  • 28.2. Middle East Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Self-Injections Market

  • 29.1. Africa Self-Injections Market Overview
  • 29.2. Africa Self-Injections Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Self-Injections Market Competitive Landscape And Company Profiles

  • 30.1. Self-Injections Market Competitive Landscape
  • 30.2. Self-Injections Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Self-Injections Market Other Major And Innovative Companies

  • 31.1. Bristol-Myers Squibb Company
  • 31.2. Credence MedSystems Inc.
  • 31.3. Dali Medical Devices Ltd.
  • 31.4. Eli Lilly and Company
  • 31.5. Enable Injections Inc.
  • 31.6. Gerresheimer AG
  • 31.7. Insulet Corporation
  • 31.8. Merck & Co. Inc.
  • 31.9. Owen Mumford Limited
  • 31.10. Pfizer Inc.
  • 31.11. PharmaJet Inc.
  • 31.12. Recipharm AB
  • 31.13. Schott AG
  • 31.14. SHL Group Limited
  • 31.15. Terumo Corporation

32. Global Self-Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Self-Injections Market

34. Recent Developments In The Self-Injections Market

35. Self-Injections Market High Potential Countries, Segments and Strategies

  • 35.1 Self-Injections Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Self-Injections Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Self-Injections Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer